Does enclomiphene actually suck compared to TRT?

What did @harleymeds.com actually say?

The creator's core claim is simple: if your testosterone is below 550 ng/dL, enclomiphene, HCG, and clomiphene "aren't going to do anything for you" because your body has "already stopped producing testosterone" and your "signal is shutting down." The fix, they argue, is bioidentical testosterone injections. Above 550, enclomiphene might nudge levels up a few hundred points. Below that threshold, injections are "the way to go."

To be fair, the creator does acknowledge a legitimate use for enclomiphene: maintaining fertility and testicular volume in men already on TRT. That nuance matters, and it doesn't get lost in the take.

Does the science back this up?

Partially, but the 550 ng/dL cutoff is invented. There is no peer-reviewed threshold at which enclomiphene categorically stops working. The actual evidence suggests enclomiphene raises LH, FSH, and total testosterone meaningfully in men with secondary hypogonadism, regardless of whether their baseline is 250 or 450 ng/dL.

A randomized controlled trial by Kim et al. (2013, Journal of Urology) found that enclomiphene raised total testosterone from a mean of roughly 230 ng/dL to over 400 ng/dL in men with secondary hypogonadism while preserving sperm counts, outperforming topical testosterone on fertility markers. Ramasamy et al. (2014, BJU International) replicated similar findings. Neither study identified a lower-bound baseline below which enclomiphene became inert.

The mechanism matters here. Enclomiphene blocks estrogen receptors in the hypothalamus, triggering more GnRH, which drives LH and FSH production. That process requires a functioning hypothalamic-pituitary-gonadal (HPG) axis. Men with primary hypogonadism, where the testes themselves are damaged, won't respond. But the creator conflates low testosterone with a shut-down axis, and those are not the same thing.

What did they get wrong (or right)?

The biggest error is the 550 ng/dL cutoff. It sounds clinical and precise. It isn't. There is no published study, guideline from the American Urological Association, or Endocrine Society consensus that treats 550 as a dividing line for enclomiphene efficacy. This number appears to be experiential, maybe practice-based, but presenting it as a hard physiological rule is misleading.

The creator also oversimplifies the distinction between primary and secondary hypogonadism. The real question is not "what is your testosterone level" but "why is it low." Men with secondary hypogonadism, where the problem is upstream in the hypothalamus or pituitary, can respond to enclomiphene even at very low baseline levels. Men with primary hypogonadism, damaged Leydig cells, will not, regardless of their number.

What they got right: enclomiphene is a reasonable adjunct during TRT to preserve testicular function and fertility. That is well-supported. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that adding low-dose clomiphene (a close relative) to TRT maintained intratesticular testosterone and sperm production. The creator's framing of enclomiphene as a "supporting med" on TRT is clinically defensible.

What should you actually know?

If you are considering enclomiphene, the relevant question is not your testosterone number alone. It is whether your LH and FSH are low, normal, or high. Low LH with low testosterone points to secondary hypogonadism, exactly the population enclomiphene is designed for. High LH with low testosterone points to primary hypogonadism, where enclomiphene will not help because the testes are not responding to the signal regardless of how loud it gets.

The Endocrine Society's 2018 clinical practice guidelines on male hypogonadism do not endorse enclomiphene as a first-line monotherapy, but they also do not dismiss it. Clomiphene citrate, the racemic precursor, has been used off-label for decades. Enclomiphene is the active isomer, with a cleaner side-effect profile in early trials.

• Get LH, FSH, and total testosterone tested before drawing conclusions about which therapy applies to you.
• A 550 ng/dL cutoff for enclomiphene efficacy is not grounded in published evidence.
• Enclomiphene works on the HPG axis. If your axis is intact, baseline testosterone level alone does not determine whether you will respond.
• For men who want to preserve fertility, enclomiphene alongside TRT has legitimate clinical support.
• Anyone telling you there is a single number that determines your treatment path without knowing your LH and FSH is guessing.